In breast cancer, high methylation of the ESR1 promoter mediated by DNMTs leads to reduced ERα expression, resulting in tamoxifen resistance.676,677 Moreover, methylation can also lead to tamoxifen resistance by regulating the promoter methylation of ERα-related genes. This evidence concerns the gene ESR1 and breast carcinoma.